Cyclosporin A as an Add-On Therapy to a Corticosteroid-Based Background Treatment in Patients with COVID-19 : A Multicenter, Randomized Clinical Trial

on behalf of CSACOVID-IISFJD Team2026-01-282026-01-282024-09on behalf of CSACOVID-IISFJD Team 2024, 'Cyclosporin A as an Add-On Therapy to a Corticosteroid-Based Background Treatment in Patients with COVID-19 : A Multicenter, Randomized Clinical Trial', Journal of Clinical Medicine, vol. 13, no. 17, 5242. https://doi.org/10.3390/jcm131752422077-0383PubMedCentral: PMC11396137https://hdl.handle.net/10641/7713Publisher Copyright: © 2024 by the authors.886300enghttp://creativecommons.org/licenses/by-nc-nd/4.0/COVID-19 pneumoniacyclosporin Ahyperinflammationrandomized controlled trialGeneral MedicineJournal ArticleYesyesCyclosporin A as an Add-On Therapy to a Corticosteroid-Based Background Treatment in Patients with COVID-19 : A Multicenter, Randomized Clinical Trialjournal articleopen access10.3390/jcm13175242https://www.scopus.com/pages/publications/85204004984https://www.scopus.com/pages/publications/85204004984#tab=citedBy